General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Regeneron(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: AstraZeneca Pharmaceuticals(NONE), GlaxoSmithKline(NONE), Novartis(NONE), Novo Nordisk Inc.(SIGNIFICANT), Sanofi/Regeneron(NONE), Amgen Inc.(SIGNIFICANT) OTHER FINANCIAL BENEFIT: G3 Therapeutics(SIGNIFICANT)

View Full Disclosure